Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment showed a higher response rate but no significant survival benefits.

ICP5249 helps hair grow by activating a specific cell pathway.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Dkk4 is necessary for the initial development and arrangement of hair follicles.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

ITK inhibitors may effectively treat alopecia areata.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Gefitinib can cause hair and eyebrow darkening.

Three compounds from Dadap leaves may help treat hair loss.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Applying a specific inhibitor lightens skin and hair color.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Keratin K6irs is a marker for the inner root sheath of hair follicles in mice and humans.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Scientists can control how skin stem cells divide by using different treatments.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Tadalafil and Finasteride may help treat aggressive melanoma.